Stay updated with breaking news from Jay Flatley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Carl Icahn shares common ground with the FTC, which argued that Illumina’s acquisition of cancer test developer Grail would stifle competition and...
Carl Icahn shares common ground with the FTC, which argued that Illumina’s acquisition of cancer test developer Grail would stifle competition and...
By Denny Jacob The U.S. Federal Trade Commission on Monday said it issued an opinion and order requiring biotechnology company Illumina Inc. to divest cancer-screening company Grail Inc.,... | April 3, 2023
Rafael Henrique | Light Rocket | Getty Images
The move by the commission is seen as a test of regulators’ efforts to prevent big companies from buying small innovators.